GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
71 hedge funds and large institutions have $38.2M invested in GALENA BIOPHARMA INC COM in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 16 closing their positions.
1,187% more call options, than puts
Call options by funds: $8.5M | Put options by funds: $661K
209% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 11
4% less capital invested
Capital invested by funds: $39.8M → $38.2M (-$1.67M)
14% less funds holding
Funds holding: 83 → 71 (-12)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.33M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$498K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$224K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$201K |
| 5 |
D.E. Shaw & Co
New York
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$1.98M |
| 2 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$179K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$61.6K |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$44.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$36.5K |
RXII Hedge Fund Activity: Q1 2016 in Review
71 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q1 2016, worth a combined $38.2M — down 4.2% from $39.8M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of RXII and 5 opened new positions — a net loss of 11 holders — while 11 trimmed existing stakes and 34 added.
The largest buyer was Vanguard Group, adding an estimated $1.33M. The largest seller was Group One Trading, exiting entirely with an estimated $1.98M sold.
- 71 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q1 2016, down from 83 in Q4 2015.
- Funds reported $38.2M of GALENA BIOPHARMA INC COM stock for Q1 2016, down 4.2% quarter-over-quarter.
- 5 funds opened new GALENA BIOPHARMA INC COM positions in Q1 2016 and 16 closed out, a net change of -11 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q1 2016 was Vanguard Group, an estimated $1.33M added.
- The largest GALENA BIOPHARMA INC COM seller in Q1 2016 was Group One Trading, an estimated $1.98M sold.
Based on aggregated 13F filings for Q1 2016.